Table 7.

The relationships of stress scores with menstrual characteristics of the study population after COVID-19 via multiple linear regression.

Menstrual characteristics	B	95% CI	SE	p values
Cycle length (days)	−0.014	−0.049–0.021	0.018	0.42
Bleeding days	0.071	−0.338–0.481	0.208	0.732
Heavy bleeding days number	−0.053	−0.324–0.219	−0.019	0.704
Pads per day	0.073	−0.166–0.312	0.122	0.55
Pads per night	−0.466	−1.238–0.306	−0.060	0.236
Bleeding amount
Mild	1.049	−0.752–2.850	0.916	0.05*
Moderate	−1.961	−3.322 – −0.600	0.692	0.005**
Heavy	1.683	0.157–3.210	0.776	0.110
Indicators for heavy menstrual bleeding
Double protection	−1.099	−2.499–0.301	0.712	0.124
Night leak after	0.653	−0.732–2.038	0.704	0.355
Clots	0.217	−1.461–1.895	0.853	0.800
Anemia	−1.144	−2.689–0.402	0.786	0.146
Symptoms of menstruation
Nausea and/or vomiting	1.663	0.249–3.077	0.719	0.021*
Consumption and/or diarrhea	−0.811	−2.592–970	0.906	0.371
Flatulence	−0.579	−3.130–1.972	1.297	0.656
Breast pain	−0.087	−1.0673–1.500	0.807	0.914
Fatigue	−3.402	−7.916–1.111	2.296	0.139
Appetite change	0.747	−1.601–3.095	1.194	0.532
Headache	−0.133	−1.803–1.538	0.850	0.876
Urgency	1.656	0.211–3.101	0.735	0.025*
Mood swing	−0.036	−3.117–3.046	1.567	0.982
Anger	0.202	−2.389–2.793	1.318	0.878
Acne	1.087	−1.177–3.351	1.151	0.346
Irregular bleeding between period	−0.667	−2.060–.726	0.708	0.347
Light or absent period	−0.69	−1.476–1.339	0.716	0.924
Six-month absence	3.058	−0.084–6.201	1.598	0.05*
Menstrual disorders treatment
Unknown	−7.393	−14.09–−0.689	3.410	0.031*
Hormonal	0.899	−3.626–5.425	2.302	0.696
Herbs	−1.734	−3.279–−0.189	0.786	0.028*
Contraception	2.970	−0.671–6.612	1.852	0.110
Surgery	3.954	−5.551–13.460	4.834	0.414
Others	2.706	0.594–4.817	1.074	0.012*

CI: confidence interval; SE: standard error.

^*p ⩽ 0.05.

^**p ⩽ 0.01.